Feasibility of ESWT Treatment in Post-stroke Patients With Triceps Sural Spasticity

NCT ID: NCT05255549

Last Updated: 2025-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-22

Study Completion Date

2022-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to evaluate the feasibility of two different rehabilitation protocols that differed from the number of treatment sessions (1 session of ESWT versus 3 weekly sessions of ESWT), in patients with triceps surae spasticity after stroke. In both arms the other ESWT parameters (types of ESWT, intensity, frequency, location) and stretching sessions are the same.

Secondary objectives: to compare functional performances in these two groups of patients receiving the different rehabilitation protocol with ESWT, using the following parameters:

\- Six Minutes walking test (6MWT) ; - Time Up \& Go (TUG); - Modified Ashworth scale (MAS); - Lower Extremity Functional Scale (LEFS); - passive ankle range of motion (p-ROM), pain (NRS); and presence of ankle clonus. These parameters are assessed during baseline (T0), after 4 weeks (T1) and after 12 weeks (T2).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

Group Type EXPERIMENTAL

ESWT + Stretching

Intervention Type PROCEDURE

3 weeks intervention:

* 3 sessions of ESWT, once a week
* 6 sessions of passive stretching, twice a week

Group II

Group Type SHAM_COMPARATOR

ESWT and SHAM + Stretching

Intervention Type PROCEDURE

3 weeks intervention:

* 1 sessions of ESWT + 2 sessions of Sham, once a week
* 6 sessions of passive stretching, twice a week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESWT + Stretching

3 weeks intervention:

* 3 sessions of ESWT, once a week
* 6 sessions of passive stretching, twice a week

Intervention Type PROCEDURE

ESWT and SHAM + Stretching

3 weeks intervention:

* 1 sessions of ESWT + 2 sessions of Sham, once a week
* 6 sessions of passive stretching, twice a week

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients of legal age
* Time elapsed since the stroke between 6 and 60 months
* Autonomous or supervised walking with or without aids
* Spasticity of the sural triceps\> 1 on the MAS scale

Exclusion Criteria

* Joint stiffness of the lower limbs due to other pathologies (ex orthopedic or rheumatological);
* Conditions that interfere with evaluation or collaboration in rehabilitation treatment (major psychiatric illnesses, clearly detectable cognitive deficits, severe pre-existing disabilities, sensory disturbances, etc.)
* Focal antispasmodic toxin treatments in the previous 3 months or phenolic blocks in the previous 9 months in the treatment region
* Treatments with central antispasmodic drugs with dosage modifications in the last week of starting treatment
* Individual neurorehabilitation treatments in progress
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefania Testoni, Dr

Role: PRINCIPAL_INVESTIGATOR

Azienda AUSLRE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Operational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia

Reggio Emilia, Emilia-Romagna, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

31032021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.